Clinical Trial Update: Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating N-acetylcysteine (NAC) to prevent chemotherapy-related cognitive impairment in ovarian cancer patients treated with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Ovarian Cancer

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of California, Irvine | Conditions: Ovarian Cancer, Cognitive Impairment | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING